Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Baxter International Inc.
Headquarters: Deerfield, IL, United States of America
Website: http://www.baxter.com
Year Founded: 1931
Status: Public
Industry Sector: HealthTechnology
CEO: D. Brent Shafer, MD
Number Of Employees: 38,000
Enterprise Value: $26,614,600,000
PE Ratio: -27.17
Exchange/Ticker 1: NYSE:BAX
Exchange/Ticker 2: N/A
Latest Market Cap: $17,676,644,352
BioCentury | Mar 7, 2025
Management Tracks
Abbas Kazimi succeeds Jeb Keiper as CEO of Nimbus
Plus: Jon Garay Alonso named CFO of Almirall, and updates from Certara and Immunai
BioCentury | Apr 16, 2024
Management Tracks
Viatris hires Corinne Le Goff as commercial head
Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | May 9, 2023
Deals
May 8 Quick Takes: EQRx reset brings end of China deals, layoffs
Plus: Legend’s $350M raise helps May follow-ons top April tally; ADC deals by Eisai-BlissBio, FibroGen-Fortis; and more
BioCentury | Mar 28, 2023
Finance
Sofinnova Partners’ digital strategy to address ‘sea change’ in data, computation and biology
Pair of partners to lead firm’s sixth official strategy backing start-ups with healthcare-enabling tech, analytics and digital therapeutics
BioCentury | Jan 31, 2023
Management Tracks
Baxter’s Accogli named CEO of Chiesi
Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
BioCentury | Mar 9, 2022
Management Tracks
Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO
Plus updates from Centessa, Teon, AnchorDx, Pillar and more
BioCentury | Jan 21, 2022
Emerging Company Profile
ImmPACT: uniting CAR T platforms for ‘logic-gate’ therapies
Los Angeles-area biotech has $111M series B, early clinical data in hand as it advances bispecific CAR T
BioCentury | Oct 6, 2021
Management Tracks
Weinstein becomes CFO at Caris Life Sciences
Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
BioCentury | Sep 9, 2021
Management Tracks
Hayes joins Fulcrum as chief commercial officer
Plus: ImmunityBio, Finch, Rhythm, Infinity, Locanabio and more
BioCentury | Feb 5, 2021
Product Development
Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair
Focus will be on modest, early-stage deals as the pharma seeks next blockbuster
Items per page:
1 - 10 of 655